Sienna Diagnostics Inks Singapore Distribution Deal for Bladder Cancer Test

Dec

Evolution of Tumor Profiling in a Clinical Lab: Moving toward Comprehensive Genomic Profiling

This webinar will provide a first-hand look at how a clinical lab evolved its tumor profiling workflow from a targeted panel approach toward comprehensive genomic profiling.

Jan

Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Menu

Sienna Diagnostics Inks Singapore Distribution Deal for Bladder Cancer Test

To read the full story....

Breaking News

GenMark Diagnostics Downgraded by JP Morgan to Neutral

Parkinson's Foundation Selects Five Sites for Genetic Testing, Counseling

Proscia, Johns Hopkins Collaborate on AI for Pathology

At ASH, Researchers Discuss Rapid AML Nanopore Sequencing Assay for Analyzing Actionable Alterations

Enzo Biochem Fiscal Q1 Revenues Down 5 Percent

Seventh Sense Biosystems Gets FDA Clearance for At-Home Blood Collection Device

Featured White Papers

Evolution of Tumor Profiling in a Clinical Lab: Moving toward Comprehensive Genomic Profiling

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

What's Popular?

At ASH, Researchers Discuss Rapid AML Nanopore Sequencing Assay for Analyzing Actionable Alterations

Adaptive Biotechnologies, AbbVie Partner on MRD Testing in Multiple Myeloma Drug Trials

KU-Led Team Begins Clinical Validation of Microfluidic Device for Leukemia MRD Detection

Array Genomics Sets Out to Build Business for Bladder Cancer Test

Co-Diagnostics Continues Global Expansion With Africa Alliance, New India Facility

Sponsorships